Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06181266
Title A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)
Acronym PARADIGM-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Prokarium Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.